Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2024 Filed Mar 19, 2024 19:39 UTC |
Valencia Catalina10% owner
|
GrantConvertible Note · Derivative | 7,837,500 | $156,750.00 Strike: $0.02 | $1,228,528,125,000.00 |
DisclosureSEC source: 0001096906-24-000524 · form4.xml · derivative · entry 1 Valencia Catalina · CIK 0001944813 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,837,500 Underlying: Common Stock · 7,837,500 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a convertible note, face value $156,750. The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares.. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:24 UTC |
O'Rourke PeterDirector
|
GrantConvertible Note · Derivative | 35,000 | $35,000.00 Strike: $0.01 | $1,225,000,000.00 |
DisclosureSEC source: 0001096906-24-000515 · form4.xml · derivative · entry 1 O'Rourke Peter · CIK 0001890749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500,000 Underlying: Common Stock · 3,500,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:16 UTC |
MALASEK ROBERTChief Financial Officer
|
GrantConvertible Note · Derivative | 53,500 | $53,500.00 Strike: $0.02 | $2,862,250,000.00 |
DisclosureSEC source: 0001096906-24-000511 · form4.xml · derivative · entry 1 MALASEK ROBERT · CIK 0001493185 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,475,000 Underlying: Common Stock · 2,675,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a Convertible Note face $53,500. The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:59 UTC Amendment |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantConvertible Note · Derivative | 250,000 | $250,000.00 Strike: $0.02 | $62,500,000,000.00 |
DisclosureSEC source: 0001096906-24-000525 · form4.xml · derivative · entry 2 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500,000 Underlying: Common Stock · 12,500,000 shares Expires 2034-03-01 F2 · shares: Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:59 UTC Amendment |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantConvertible Note · Derivative | 250,000 | $250,000.00 Strike: $0.01 | $62,500,000,000.00 |
DisclosureSEC source: 0001096906-24-000525 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000,000 Underlying: Common Stock · 25,000,000 shares Expires 2033-01-24 F1 · shares: Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:37 UTC |
Schroeder BlakeDirector
|
GrantConvertible Note · Derivative | 35,000 | $35,000.00 Strike: $0.01 | $1,225,000,000.00 |
DisclosureSEC source: 0001096906-24-000522 · form4.xml · derivative · entry 1 Schroeder Blake · CIK 0001708685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500,000 Underlying: Common Stock · 3,500,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:29 UTC |
Scott Timothy RichardDirector
|
GrantConvertible Note · Derivative | 35,000 | $35,000.00 Strike: $0.01 | $1,225,000,000.00 |
DisclosureSEC source: 0001096906-24-000517 · form4.xml · derivative · entry 1 Scott Timothy Richard · CIK 0001709014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500,000 Underlying: Common Stock · 3,500,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:33 UTC |
Cunningham Robert LDirector
|
GrantConvertible Note · Derivative | 35,000 | $35,000.00 Strike: $0.01 | $1,225,000,000.00 |
DisclosureSEC source: 0001096906-24-000520 · form4.xml · derivative · entry 1 Cunningham Robert L · CIK 0001708731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500,000 Underlying: Common Stock · 3,500,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a Convertible Note, face value $35,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 19:14 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantConvertible Note · Derivative | 1 | $250,000.00 Strike: $0.02 | $250,000.00 |
DisclosureSEC source: 0001096906-24-000509 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500,000 Underlying: Common Stock · 12,500,000 shares Expires 2034-03-01 F1 · shares: Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share. Read SEC document |
| January 30, 2024 Filed Oct 15, 2024 17:05 UTC |
Valencia CatalinaDirector · President and Director · 10% owner
|
PurchaseCommon Stock | 1,086,216 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096906-24-002004 · form4.xml · nonDerivative · entry 1 Valencia Catalina · CIK 0001944813 · Director · President and Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,608,220 F1 · price: Acquired from third party Read SEC document |
| September 23, 2022 Filed Sep 23, 2022 16:33 UTC |
MALASEK ROBERTChief Financial Officer
|
GrantOption · Derivative | 500,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001096906-22-002337 · form4.xml · derivative · entry 1 MALASEK ROBERT · CIK 0001493185 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 500,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: Reporting Person acquired an option to purchase up to 500,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. Read SEC document |
| September 23, 2022 Filed Sep 23, 2022 18:06 UTC |
Schroeder BlakeDirector
|
GrantOption · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001096906-22-002340 · form4.xml · derivative · entry 1 Schroeder Blake · CIK 0001708685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. Read SEC document |
| September 23, 2022 Filed Sep 23, 2022 16:29 UTC |
Cunningham Robert LDirector
|
GrantOption · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001096906-22-002335 · form4.xml · derivative · entry 1 Cunningham Robert L · CIK 0001708731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,000,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. Read SEC document |
| September 23, 2022 Filed Sep 23, 2022 16:25 UTC |
Scott Timothy RichardDirector
|
GrantOption · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001096906-22-002333 · form4.xml · derivative · entry 1 Scott Timothy Richard · CIK 0001709014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,000,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. Read SEC document |
| September 23, 2022 Filed Sep 23, 2022 16:20 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantOption · Derivative | 5,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001096906-22-002331 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: Reporting Person acquired an option to purchase up to 5,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. Read SEC document |
| August 24, 2022 Filed Aug 31, 2022 16:01 UTC |
Valencia Catalina10% owner
|
PurchaseCommon Stock | 3,861,004 | $0.03 | $100,000.00 |
DisclosureSEC source: 0001096906-22-002075 · form4.xml · nonDerivative · entry 1 Valencia Catalina · CIK 0001944813 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,661,004 Read SEC document |
| August 22, 2022 Filed Aug 26, 2022 17:05 UTC |
Schroeder BlakeDirector
|
ConversionCommon Stock | 854,012 | $0.03 | $24,766.35 |
DisclosureSEC source: 0001096906-22-002027 · form4.xml · nonDerivative · entry 1 Schroeder Blake · CIK 0001708685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 854,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Conversion of Note Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 18:04 UTC |
Schroeder BlakeDirector
|
OtherConvertible Note (Convertible into Common Stock) · Derivative | 25,000 | $25,000.00 Strike: $0.08 | $625,000,000.00 |
DisclosureSEC source: 0001096906-22-000339 · form4.xml · derivative · entry 1 Schroeder Blake · CIK 0001708685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,692 Underlying: Common Stock · 307,692 shares Expires 2032-02-10 F1 · kind: This Note bears interest at a rate of 3% per annum. At the election of the Reporting Person, all principal and accrued interest under the Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion. Read SEC document |
| May 06, 2021 Filed Sep 23, 2022 16:17 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
Disposition to issuerOption · Derivative | 2,000,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001096906-22-002330 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2039-01-01 F1 · kind: On May 6, 2021, Reporting Person voluntarily agreed to cancel the option to purchase 2,000,000 shares of the Issuer's common stock granted to Reporting Person on January 2, 2019. Read SEC document |
| December 10, 2020 Filed Sep 23, 2022 16:31 UTC |
MALASEK ROBERTChief Financial Officer
|
GrantOption · Derivative | 300,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001096906-22-002336 · form4.xml · derivative · entry 1 MALASEK ROBERT · CIK 0001493185 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2030-12-10 Read SEC document |
| December 10, 2020 Filed Sep 23, 2022 16:16 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantOption · Derivative | 3,000,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001096906-22-002329 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2030-12-10 Read SEC document |
| May 13, 2020 Filed Sep 23, 2022 16:27 UTC |
Cunningham Robert LDirector
|
GrantOption · Derivative | 500,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001096906-22-002334 · form4.xml · derivative · entry 1 Cunningham Robert L · CIK 0001708731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-03-13 F1 · derivative.exercise_date: Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock ("Option Shares") on May 13, 2020 (the "Date of Grant"). One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of the Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date. In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service. Read SEC document |
| May 13, 2020 Filed Sep 23, 2022 16:22 UTC |
Scott Timothy RichardDirector
|
GrantOption · Derivative | 500,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001096906-22-002332 · form4.xml · derivative · entry 1 Scott Timothy Richard · CIK 0001709014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-03-13 F1 · derivative.exercise_date: Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock ("Option Shares") on May 13, 2020 (the "Date of Grant"). One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date. In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service. Read SEC document |
| March 19, 2020 Filed Sep 23, 2022 16:14 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
PurchaseCommon Stock | 6,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096906-22-002328 · form4.xml · nonDerivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000,000 F1 · price: Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer. Read SEC document |
| January 02, 2019 Filed Sep 23, 2022 16:11 UTC |
HUEMOELLER JOHN WALTER IIDirector · Chief Executive Officer
|
GrantOption · Derivative | 2,000,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001096906-22-002327 · form4.xml · derivative · entry 1 HUEMOELLER JOHN WALTER II · CIK 0001568485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2039-01-01 F1 · derivative.exercise_date: On January 2, 2019, Reporting Person acquired an option to purchase up to 2,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may be purchased at the date which is six (6) months following the grant date. Read SEC document |
| March 21, 2018 Filed Apr 6, 2018 15:35 UTC | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000415 · primary_doc.xml · nonDerivative · entry 1 MALASEK ROBERT · CIK 0001493185 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
|
| December 02, 2016 Filed Feb 15, 2017 21:01 UTC |
Medical Marijuana Inc10% owner
|
GrantCommon Stock | 7,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000218 · primary_doc.xml · nonDerivative · entry 1 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,143,650 F1 · ownership.direct: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,443,650 shares of common stock. Read SEC document |
| December 02, 2016 Filed Feb 28, 2017 19:11 UTC Amendment |
Medical Marijuana Inc10% owner
|
GrantCommon Stock | 7,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000274 · primary_doc.xml · nonDerivative · entry 1 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,669,125 F1 · ownership.direct: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 21:01 UTC |
Medical Marijuana Inc10% owner
|
GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000218 · primary_doc.xml · nonDerivative · entry 2 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F2 · ownership.direct: Reporting person holds 500,000 shares of Series C Preferred Stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:20 UTC |
Anastassov GeorgeDirector · CEO/Secretary · 10% owner
|
GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000216 · primary_doc.xml · nonDerivative · entry 3 Anastassov George · CIK 0001604392 · Director · CEO/Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 500,000 F2 · ownership.direct: Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B preferred stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:20 UTC |
Anastassov GeorgeDirector · CEO/Secretary · 10% owner
|
GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000216 · primary_doc.xml · nonDerivative · entry 2 Anastassov George · CIK 0001604392 · Director · CEO/Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,002,000 F1 · ownership.direct: Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Anastassov is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:20 UTC |
Anastassov GeorgeDirector · CEO/Secretary · 10% owner
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000216 · primary_doc.xml · nonDerivative · entry 1 Anastassov George · CIK 0001604392 · Director · CEO/Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,002,000 F1 · ownership.direct: Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Anastassov is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC |
Changoer LekhramDirector · 10% owner
|
GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 3 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 500,000 F2 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B Preferred Stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC |
Changoer LekhramDirector · 10% owner
|
GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 2 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265,000 F1 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC |
Changoer LekhramDirector · 10% owner
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 1 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265,000 F1 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 28, 2017 19:11 UTC Amendment |
Medical Marijuana Inc10% owner
|
GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000274 · primary_doc.xml · nonDerivative · entry 2 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F2 · ownership.direct: Reporting person holds 500,000 shares of Series C Preferred Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.